43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA

BACKGROUND: A large number of clinical and preclinical studies suggest that dysfunction at synapses for the excitatory neurotransmitter glutamate may play a critical role in the pathophysiological changes that underlie each of the major symptom clusters observed in schizophrenia patients. Interestin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Schizophr Bull
Autores principales: Conn, P Jeffrey, Yohn, Samantha, Stansley, Branden, Foster, Dan, Plumley, Hyekyung, Lindsley, Craig
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887675/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.179
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares